32 related articles for article (PubMed ID: 14499242)
1. Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection.
Bryant J; Lerret NM; Wang JJ; Kang HK; Tasch J; Zhang Z; Luo X
J Immunol; 2014 Jun; 192(12):6092-101. PubMed ID: 24808363
[TBL] [Abstract][Full Text] [Related]
2. ECDI-fixed donor splenocytes prolong skin allograft survival by promoting M2 macrophage polarization and inducing regulatory T cells.
Zhou B; Zhang Y; Zhang D; Zhang Y; Xie J; Zhang X; Ding J; Su Y; Guo S; Zhuang R
FASEB Bioadv; 2019 Nov; 1(11):706-718. PubMed ID: 32123816
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle dose and antigen loading attenuate antigen-specific T-cell responses.
Casey LM; Decker JT; Podojil JR; Rad L; Hughes KR; Rose JA; Pearson RM; Miller SD; Shea LD
Biotechnol Bioeng; 2023 Jan; 120(1):284-296. PubMed ID: 36221192
[TBL] [Abstract][Full Text] [Related]
4. Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment.
Mashayekhi K; Khazaie K; Faubion WA; Kim GB
Bioact Mater; 2024 Jul; 37():269-298. PubMed ID: 38694761
[TBL] [Abstract][Full Text] [Related]
5. Engineering Cell Membrane-Based Nanotherapeutics to Target Inflammation.
Yan H; Shao D; Lao YH; Li M; Hu H; Leong KW
Adv Sci (Weinh); 2019 Aug; 6(15):1900605. PubMed ID: 31406672
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic cell-based therapies for promoting transplantation tolerance.
Dangi A; Yu S; Luo X
Curr Opin Organ Transplant; 2018 Oct; 23(5):552-558. PubMed ID: 30024416
[TBL] [Abstract][Full Text] [Related]
7. Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy.
Li PY; Fan Z; Cheng H
Bioconjug Chem; 2018 Mar; 29(3):624-634. PubMed ID: 29323870
[TBL] [Abstract][Full Text] [Related]
8. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells.
McCarthy DP; Bryant J; Galvin JP; Miller SD; Luo X
Am J Transplant; 2015 Jun; 15(6):1475-83. PubMed ID: 25807873
[TBL] [Abstract][Full Text] [Related]
9. Targeted immunomodulation using antigen-conjugated nanoparticles.
McCarthy DP; Hunter ZN; Chackerian B; Shea LD; Miller SD
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(3):298-315. PubMed ID: 24616452
[TBL] [Abstract][Full Text] [Related]
10. Exploiting apoptosis for therapeutic tolerance induction.
Getts DR; McCarthy DP; Miller SD
J Immunol; 2013 Dec; 191(11):5341-6. PubMed ID: 24244028
[TBL] [Abstract][Full Text] [Related]
11. Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions.
Chen G; Kheradmand T; Bryant J; Wang S; Tasch J; Wang JJ; Zhang Z; Luo X
Am J Transplant; 2012 Nov; 12(11):2920-9. PubMed ID: 22883222
[TBL] [Abstract][Full Text] [Related]
12. Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.
Martin AJ; McCarthy D; Waltenbaugh C; Goings G; Luo X; Miller SD
J Immunol; 2010 Sep; 185(6):3326-36. PubMed ID: 20713889
[TBL] [Abstract][Full Text] [Related]
13. Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.
Albert MH; Yu XZ; Magg T
Clin Immunol; 2008 Dec; 129(3):381-93. PubMed ID: 18819845
[TBL] [Abstract][Full Text] [Related]
14. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms.
Luo X; Pothoven KL; McCarthy D; DeGutes M; Martin A; Getts DR; Xia G; He J; Zhang X; Kaufman DB; Miller SD
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14527-32. PubMed ID: 18796615
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen presentation by ethylcarbodiimide-treated dendritic cells induces T cell hyporesponsiveness, and prolongs organ graft survival.
Kaneko K; Morelli AE; Wang Z; Thomson AW
Clin Immunol; 2003 Sep; 108(3):190-8. PubMed ID: 14499242
[TBL] [Abstract][Full Text] [Related]
16. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
17. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
